Britons Pay Hundreds for H.I.V. Drugs. Why Do Americans Pay Thousands?


When it comes to helping H.I.V. patients, Britain's National Health Service is able to keep prices for treatment much lower than the United States does by encouraging the use of generic drugs. The National Health Service's structure allows it to incentivize prescribing generic treatment in a way that the American system doesn't, especially as H.I.V. treatments are not being consistently replaced by something found to be more efficient.

Related Stories